“Rifampicin-Loaded Nanoparticles for Targeted Tuberculosis Therapy: Enhancing Delivery and Efficacy” (2025) Asian Journal of Pharmaceutics (AJP), 19(04). doi:10.22377/ajp.v19i04.7008.